LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 4 of 15: Mean cell count and mean growth rate across biological replicate 1. - Dataset (ID:20240)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Relative Growth Rate After Treatment |
---|---|---|---|---|---|---|---|---|---|---|---|
Hs 578T | PI103 | 0.04 | uM | LJP6 | 72 | hr | 929 | 2243 | 3228 | 0.6950 | 0.5716 |
Hs 578T | PLX-4720 | 0.04 | uM | LJP5 | 72 | hr | 929 | 3436 | 3228 | 1.0645 | 1.0906 |
Hs 578T | QL-X-138 | 0.04 | uM | LJP6 | 72 | hr | 929 | 2741 | 3228 | 0.8492 | 0.7883 |
Hs 578T | QL-XII-47 | 0.04 | uM | LJP6 | 72 | hr | 929 | 3047 | 3228 | 0.9441 | 0.9215 |
Hs 578T | Radicicol | 0.04 | uM | LJP5 | 72 | hr | 929 | 3370 | 3228 | 1.0442 | 1.0620 |
Hs 578T | Radicicol | 0.04 | uM | LJP6 | 72 | hr | 929 | 3330 | 3228 | 1.0316 | 1.0443 |
Hs 578T | Seliciclib | 0.04 | uM | LJP5 | 72 | hr | 929 | 3284 | 3228 | 1.0174 | 1.0245 |
Hs 578T | Ruxolitinib | 0.04 | uM | LJP5 | 72 | hr | 929 | 3198 | 3228 | 0.9908 | 0.9871 |
Hs 578T | XL147 | 0.04 | uM | LJP5 | 72 | hr | 929 | 3301 | 3228 | 1.0227 | 1.0319 |
Hs 578T | Saracatinib | 0.04 | uM | LJP6 | 72 | hr | 929 | 3166 | 3228 | 0.9810 | 0.9733 |
Hs 578T | Selumetinib | 0.04 | uM | LJP6 | 72 | hr | 929 | 2018 | 3228 | 0.6251 | 0.4736 |
Hs 578T | Sirolimus | 0.04 | uM | LJP6 | 72 | hr | 929 | 2228 | 3228 | 0.6904 | 0.5653 |
Hs 578T | Sorafenib | 0.04 | uM | LJP6 | 72 | hr | 929 | 3783 | 3228 | 1.1720 | 1.2415 |
Hs 578T | SU11274 | 0.04 | uM | LJP5 | 72 | hr | 929 | 3333 | 3228 | 1.0327 | 1.0459 |
Hs 578T | Fedratinib | 0.04 | uM | LJP5 | 72 | hr | 929 | 3318 | 3228 | 1.0281 | 1.0394 |
Hs 578T | TGX221 | 0.04 | uM | LJP5 | 72 | hr | 929 | 3021 | 3228 | 0.9359 | 0.9099 |
Hs 578T | Torin1 | 0.04 | uM | LJP6 | 72 | hr | 929 | 1429 | 3228 | 0.4429 | 0.2177 |
Hs 578T | Torin2 | 0.04 | uM | LJP5 | 72 | hr | 929 | 1403 | 3228 | 0.4347 | 0.2062 |
Hs 578T | Tozasertib | 0.04 | uM | LJP5 | 72 | hr | 929 | 1399 | 3228 | 0.4334 | 0.2044 |
Hs 578T | Trametinib | 0.04 | uM | LJP5 | 72 | hr | 929 | 1525 | 3228 | 0.4726 | 0.2595 |
Hs 578T | TWS119 | 0.04 | uM | LJP5 | 72 | hr | 929 | 3301 | 3228 | 1.0226 | 1.0317 |
Hs 578T | Vemurafenib | 0.04 | uM | LJP5 | 72 | hr | 929 | 3317 | 3228 | 1.0276 | 1.0387 |
Hs 578T | Withaferin A | 0.04 | uM | LJP5 | 72 | hr | 929 | 3227 | 3228 | 0.9997 | 0.9995 |
Hs 578T | Withaferin A | 0.04 | uM | LJP6 | 72 | hr | 929 | 3234 | 3228 | 1.0020 | 1.0029 |
Hs 578T | WYE-125132 | 0.04 | uM | LJP6 | 72 | hr | 929 | 1422 | 3228 | 0.4407 | 0.2146 |